Indication The AtriClip LAA Exclusion System is indicated for use in patients at high risk of thromboembolism for whom left atrial appendage exclusion is warranted. Talk to your healthcare provider if you have any questions about potential risks and benefits with this device. References 1 McCarthy, P.M. et al. (2020). Prevalence of atrial fibrillation before cardiac surgery and factors associated with concomitant ablation. J Thorac Cardiovasc Surg, 159(6):2245-2253.e15, DOI: 10.1016/j.jtcvs.2019.06.062.
2 Ong, Alexander. (2023). The Scientific Impact of Cardiac Ablation on Atrial Fibrillation. Afib Foundation. https://www.afib.org/_files/
ugd/7e5205_24040e9d2b5949aabfb5715c973a2929.pdf 3 Sridhar, A. et al. (2014). Ischemic strokes associated with atrial fibrillation -- on the rise despite major improvements in management. HRS, Abstract PO01-114.
4 Benjamin, E.J., et al. (2019). Heart Disease and Stroke Statistics — 2019 Update: A Report From the American Heart Association. Circulation, 139:e56-e528, DOI: 10.1161/CIR.0000000000000659. 5 Odutayo, A. et al. (2016). Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis. BMJ; 354:i4482. 6 Joglar, J. A. et al. (2024). 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 149(1):e1-e156. 7 Isabelle C Van Gelder, Michiel Rienstra, Karina V Bunting, Ruben Casado-Arroyo, Valeria Caso, Harry J G M Crijns, Tom J R De Potter, Jeremy Dwight, Luigina Guasti, Thorsten Hanke, et al. (2024). 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): Developed by the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC), with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Endorsed by the European Stroke Organisation (ESO), European Heart Journal, ehae176
Notes
ATRICURE EUROPE B.V. De Entree 260 1101 EE Amsterdam Pays-Bas
Tél. : +31 (0) 20-7005560 Fax : +31 (0) 20-7005561 SalesSupportEU@AtriCure.com
Europe.Atricure.com PM-EU-3936A-0127-G
Made with FlippingBook - Online magazine maker